Tiziana life sciences announces death of director

New york, jan. 13, 2022 (globe newswire) -- tiziana life sciences (nasdaq: tlsa) (“tiziana”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today announced that dr. thomas adams passed away on january 9, 2022. he served as a member of tiziana life science's board of directors since february 2021.

TLSA Ratings Summary

TLSA Quant Ranking